Found 351 articles for: "Open Access"
FULL SUPPLEMENT: Research on Generalized Pustular Psoriasis
August 2026 | Volume 25 | Issue 8 | Department | 63120 | Copyright © August 2026
Generalized pustular psoriasis (GPP) is a rare and potentially life-threatening disease of immunologic dysfunction. The pathophysiology of the disease was not well understood until recently. As a...
Read MoreINDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway-Directed Management
August 2026 | Volume 25 | Issue 8 | Supplement Individual Articles | 63121 | Copyright © August 2026
Observations: Emerging epidemiologic, clinical, and real-world data establish GPP as a distinct disease entity associated with high rates of hospitalization, multisystem involvem...
Read MoreMolluscum Contagiosum in the Pediatric Population: Expert Consensus Guidance on Prevention and Treatment
August 2026 | Volume 25 | Issue 8 | Original Article | 717 | Copyright © August 2026
Background: Molluscum contagiosum (MC), caused by the molluscum contagiosum virus, is a common viral skin infection in children. MC may persist for months to years and can substa...
Read MoreUse of an Eczema Moisturizer or Cream Provides Immediate, Sustained Itch Relief in Eczema-Prone Individuals
August 2026 | Volume 25 | Issue 8 | Original Article | 737 | Copyright © August 2026
Background: Eczema is a prevalent, chronic skin condition that affects up to 10% of adults globally and is characterized by recurrent eczematous lesions. Intense itch is often th...
Read MoreEfficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Postinflammatory Hyperpigmentation
July 2026 | Volume 25 | Issue 7 | Original Article | 596 | Copyright © July 2026
Background: Melasma and postinflammatory hyperpigmentation (PIH) are common disorders of hyperpigmentation of key aesthetic concern. This study assessed the efficacy and tolerabi...
Read MoreSafety and Effectiveness of Poly-L-Lactic Acid (PLLA-SCA) for Improvement in the Appearance of Cellulite
July 2026 | Volume 25 | Issue 7 | Original Article | 649 | Copyright © July 2026
Background: Cellulite is related to collagen and elastic tissue degeneration in the dermis and hypodermis. Sculptra® poly-L-lactic acid (PLLA-SCA™) is a regenerative in...
Read MoreA Comparative Analysis of 8 Facial Cleansers Using Corneosurfametry Reveals Differentiated Irritation Potential
July 2026 | Volume 25 | Issue 7 | Original Article | 655 | Copyright © July 2026
Background: Facial cleansers can disrupt the stratum corneum and cause irritation. Selecting a cleanser that is both effective and gentle is foundational to a tailored skincare r...
Read MoreFULL SUPPLEMENT: Emerging Topical Approaches in the Management of Female Pattern Hair Loss
June 2026 | Volume 25 | Issue 6 | Department | 83250s1 | Copyright © June 2026
Alopecia can be categorized as cicatricial and non-cicatricial, with female androgenetic alopecia (AGA) and female pattern hair loss (FPHL) included in the latter category....
Read MoreINDIVIDUAL ARTICLE: Efficacy of a Dual-Serum Cosmetic System in Women With Female Pattern Hair Loss
June 2026 | Volume 25 | Issue 6 | Supplement Individual Articles | 83251s3 | Copyright © June 2026
Read MoreSafety and Effectiveness of Two Reconstitution Volumes of Poly-L-Lactic Acid for Correction of Décolletage Wrinkles
June 2026 | Volume 25 | Issue 6 | Original Article | 553 | Copyright © June 2026
Background: Aesthetic patients are increasingly aware of the contrast between rejuvenated facial skin and untreated aging skin of the décolletage, and frequently request c...
Read MoreEfficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne
June 2026 | Volume 25 | Issue 6 | Original Article | 545 | Copyright © June 2026
Background: Clascoterone cream 1% is a topical androgen receptor inhibitor approved for the treatment of acne vulgaris in patients ≥12 years of age. The American Academy of De...
Read MoreEfficacy and Safety of Clascoterone Cream 1% and Clindamycin 1.2%/Benzoyl Peroxide 5% Gel Treatment in Patients With Acne
June 2026 | Volume 25 | Issue 6 | Original Article | 537 | Copyright © June 2026
Background: Clascoterone cream 1% is a topical androgen receptor inhibitor approved to treat acne vulgaris in patients ≥12 years of age. The American Academy of Dermatology re...
Read MoreA Review of the Relationship Between Cutibacterium acnes, Biofilms, and Keratosis Pilaris
June 2026 | Volume 25 | Issue 6 | Features | e53 | Copyright © June 2026
Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel
May 2026 | Volume 25 | Issue 5 | Original Article | 413 | Copyright © May 2026
Background: Cutaneous squamous cell carcinoma (cSCC) represents a significant clinical challenge in patients with locally advanced (laCSCC) or metastatic (mCSCC) disease who are ...
Read MoreSafety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ
May 2026 | Volume 25 | Issue 5 | Original Article | 454 | Copyright © May 2026
Background: Squamous cell carcinoma in situ (isSCC) is an early-stage cutaneous malignancy that requires effective treatment to prevent progression to invasive SCC. Aminolevulini...
Read MoreTreatment of Confluent and Reticulated Papillomatosis Using Fixed-Dose Clindamycin phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel
May 2026 | Volume 25 | Issue 5 | Case Reports | 474 | Copyright © May 2026
Introduction: Confluent and reticulated papillomatosis (CARP) is a rare, non-systemic disease usually treated using oral antibiotics.Case Presentation:Read MorePembrolizumab as an Off-Label Treatment of Facial Angiosarcoma: A Case Report
May 2026 | Volume 25 | Issue 5 | Case Reports | 471 | Copyright © May 2026
Summary of Case: We report an atypical case of cutaneous angiosarcoma presenting as unilateral nasal swelling in an elderly male. The lesion was unresponsive to topical and antib...
Read MoreAn Investigator-Developed Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
April 2026 | Volume 25 | Issue 4 | Original Article | 330 | Copyright © April 2026
Background: There is an unmet demand for a post-inflammatory hyperpigmentation (PIH) treatment and prevention that is not only effective and accessible, but also safe to use in d...
Read MoreBeyond Efficacy: 0.6% Selenium Disulfide Shampoo Matches 2% Ketoconazole for Seborrheic Dermatitis with Superior Cosmesis
April 2026 | Volume 25 | Issue 4 | Original Article | 338 | Copyright © April 2026
Background: Although most dandruff shampoos are effective, many leave hair dry and unmanageable, potentially impacting patient compliance and treatment outcomes.Obje...
Read MoreEfficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
March 2026 | Volume 25 | Issue 3 | Original Article | 204 | Copyright © March 2026
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
